Dandruff (Seborrheic Dermatitis): A Complete Medical Guide
Overview
Seborrheic dermatitis, commonly known as dandruff when it affects the scalp, is a chronic inflammatory skin condition that primarily targets oily (sebaceous) areas of the body. These include the scalp, eyebrows, eyelids, nasolabial folds, ears, chest, and back. The disorder is characterized by flaking, itching, and erythema (redness) of the skin.
Who it affects: Both men and women can develop seborrheic dermatitis, but it is slightly more prevalent in men (approximately 55âŻ% of cases) and in individuals between the ages of 20â50. The condition also occurs more frequently in infants (often called cradle cap) and in older adults.
Prevalence: Global estimates suggest that 3â5âŻ% of the adult population has clinically significant seborrheic dermatitis, while up to 20âŻ% may experience mild flaking that does not meet diagnostic criteria. Prevalence is higher in people with neurological diseases (e.g., Parkinsonâs disease) and in immunocompromised patients (up to 75âŻ% in HIVâpositive individuals) [1][2].
Symptoms
The clinical presentation can vary depending on the affected site and severity. Common symptoms include:
- White or yellowish flakes that are easily brushed off the scalp or hair.
- Itching (pruritus) ranging from mild to severe, often worsening after washing.
- Red, greasy patches (macules) that may feel oily to the touch.
- Scaling that can be fine (dandruff) or thick (crusty plaques) especially in the eyebrows, nasolabial folds, and behind the ears.
- Hair loss (temporary) due to scratching or severe inflammation.
- Soreness or burning sensation in affected areas.
- Secondary bacterial or fungal infection signsâpain, drainage, increased rednessâif the skin barrier is disrupted.
Causes and Risk Factors
Underlying Pathophysiology
Exact etiology remains multifactorial:
- Malassezia yeasts (especially M. globosa and M. restricta) proliferate in oily skin, producing irritant fatty acids that trigger inflammation.
- Sebaceous gland activity â increased sebum provides a nutrientârich environment for Malassezia.
- Immune dysregulation â an abnormal immune response to the yeast or its metabolites.
Risk Factors
- Age: peaks in adolescence (hormonal surge â more sebum) and after age 50.
- Male gender.
- Neurologic disease (Parkinsonâs, stroke, traumatic brain injury).
- Immunosuppression (HIV/AIDS, organ transplantation, chemotherapy).
- Concurrent skin disorders: psoriasis, rosacea, atopic dermatitis.
- Climate: colder, drier climates tend to exacerbate flaking; hot, humid climates can worsen greasiness.
- Stress and fatigue â they can increase sebum production and alter immune function.
- Certain medications: lithium, interferonâalpha, psoralenâUV therapy.
Diagnosis
Diagnosis is primarily clinical, based on history and visual examination.
Stepâbyâstep approach
- History taking: onset, pattern of flaking, itch severity, associated skin conditions, medication list, and any systemic illnesses.
- Physical exam: look for characteristic greasy, yellowâwhite scaling on scalp, eyebrows, and nasolabial folds; assess for erythema and secondary infection.
- Differential diagnosis â distinguish from psoriasis, atopic dermatitis, contact dermatitis, tinea capitis, and scalp psoriasis.
Diagnostic tests (when needed)
- Skin scrapings examined with potassium hydroxide (KOH) to rule out tinea (fungal infection).
- Culture or PCR for Malassezia species (rarely needed).
- Biopsy in atypical cases to exclude eczema or neoplastic processes.
Treatment Options
Treatment goals are to reduce yeast overgrowth, control inflammation, and restore the skin barrier. Regimens often combine medicated shampoos, topical agents, and lifestyle modifications.
1. Medicated Shampoos (firstâline for scalp involvement)
| Active Ingredient | Mechanism | Typical Use |
|---|---|---|
| Zinc pyrithione (1âŻ%) | Antifungal & antibacterial | 2â3 times weekly; leave on 5âŻmin |
| Selenium sulfide (1âŻ%) | Reduces Malassezia growth | Twice weekly; 5â10âŻmin |
| Ketoconazole (2âŻ%) | Broadâspectrum antifungal | 2âŻĂ/week; 5âŻmin |
| Coal tar (0.5â2âŻ%) | Antiâproliferative, antiâinflammatory | Twice weekly; 5â10âŻmin |
| Salicylic acid (2âŻ%) | Keratinolytic â removes scale | As needed; may need conditioner after |
2. Topical Corticosteroids
Lowâ to midâpotency steroids (e.g., hydrocortisone 1âŻ% or triamcinolone 0.1âŻ%) applied to affected nonâscalp skin for 2â4âŻweeks can reduce erythema and itching. Use sparingly to avoid skin atrophy.
3. Topical Antifungals (nonâshampoo)
Cremes or lotions containing clotrimazole, miconazole, or ciclopirox are useful for eyebrows, facial folds, and chest.
4. Calcineurin Inhibitors
Topical tacrolimus 0.1âŻ% or pimecrolimus 1âŻ% are steroidâsparing options, especially for delicate facial skin. They modulate immune response without the risk of skin thinning [3].
5. Systemic Therapy (for severe or refractory disease)
- Oral antifungals â fluconazole 100â200âŻmg weekly or itraconazole 200âŻmg twice daily for 1âŻweek per month.
- Systemic corticosteroids â short courses in acute flares, rarely used longâterm.
- Biologic agents â emerging data on ILâ17/ILâ23 inhibitors for patients with concurrent psoriasis.
6. Lifestyle & Adjunct Measures
- Gentle shampooing 2â3âŻtimes weekly to control sebum, avoiding harsh detergents.
- Regular use of a softâbristle brush to distribute scalp oils evenly.
- Stressâreduction techniques (yoga, meditation) â stress can exacerbate flares.
- Dietary considerations: limiting excessive saturated fats and sugar may help some patients.
Living with Dandruff (Seborrheic Dermatitis)
Daily Management Tips
- Stick to a shampoo schedule. Use an antiâMalassezia shampoo at least twice a week; rotate between two different active agents to prevent tolerance.
- Apply topical treatments after washing. While the skin is still slightly damp, apply antifungal cream or lowâpotency steroid to affected nonâscalp areas.
- Avoid irritants. Harsh hair styling products, alcoholâbased toners, and strong fragrances can worsen inflammation.
- Maintain a healthy scalp barrier. Use a lightweight, nonâcomedogenic conditioner on the ends of hair only; avoid leaving conditioner on the scalp.
- Monitor triggers. Keep a simple journal noting flareâups related to stress, weather changes, or new products.
- Protect the skin in cold weather. Wear breathable hats, and moisturize facial folds with a fragranceâfree emollient.
- Regular followâup. Reâevaluate with a dermatologist every 3â6âŻmonths or sooner if symptoms change.
Prevention
- Maintain scalp hygiene â wash regularly but avoid overâwashing, which can strip natural oils and paradoxically increase sebum production.
- Use antiâfungal or antiâseborrheic shampoos prophylactically during highârisk seasons (winter).
- Limit alcohol and tobacco use, both of which can impair the skin barrier and immune response.
- Manage underlying conditions (e.g., HIV, Parkinsonâs) with appropriate medical therapy.
- Adopt stressâmanagement strategies: regular exercise, adequate sleep, mindfulness.
Complications
If left untreated or poorly controlled, seborrheic dermatitis can lead to:
- Secondary bacterial infection â impetiginization, cellulitis.
- Scarring alopecia â permanent hair loss from chronic inflammation.
- Exacerbation of other skin diseases (e.g., psoriasis) due to Koebner phenomenon.
- Social and psychological impact â embarrassment, decreased selfâesteem, and in severe cases, depression.
When to Seek Emergency Care
- Sudden, severe swelling of the scalp or face accompanied by difficulty breathing or swallowing.
- Rapidly spreading redness with warmth, fever, or pus â signs of cellulitis or abscess.
- Severe, unrelenting headache or neurological symptoms (confusion, vision changes) in a patient with known severe seborrheic dermatitis, especially if associated with fever â rare but possible in immunocompromised individuals.
These situations require immediate medical attention to prevent lifeâthreatening infection or complications.
Sources:
- Mayo Clinic. âSeborrheic Dermatitis.â Updated 2023. https://www.mayoclinic.org
- CDC. âHIV and Skin Conditions.â 2022. https://www.cdc.gov
- Cleveland Clinic. âTopical Calcineurin Inhibitors for Skin Disorders.â 2024. https://my.clevelandclinic.org